EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Amorphous Solid Dispersion Formation for Enhanced Release Performance of Racemic and Enantiopure Praziquantel

Hector Polyzois, Hanh Thuy Nguyen, Benedito Roberto de Alvarenga Junior, Lynne S Taylor iD

Molecular Pharmaceutics · 2024

DOI: 10.1021/acs.molpharmaceut.4c00711 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2024. Verfasst von Hector Polyzois und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Industrial and Molecular Pharmaceutics, College of Pharmacy, Purdue University, West Lafayette, Indiana 47907, United States. Hauptthemen laut MEDLINE: Praziquantel, Methylcellulose, Hypromellose Derivatives, Crystallization. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Bill and Melinda Gates Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Praziquantel (PZQ) is the treatment of choice for schistosomiasis, which affects more than 250 million people globally. Commercial tablets contain the crystalline racemic compound (RS-PZQ) which limits drug dissolution and oral bioavailability and can lead to unwanted side effects and poor patient compliance due to the presence of the S-enantiomer. While many approaches have been explored for improving PZQ's dissolution and oral bioavailability, studies focusing on investigating its release from amorphous solid dispersions (ASDs) have been limited. In this work, nucleation induction time experiments were performed to identify suitable polymers for preparing ASDs using RS-PZQ and R-PZQ, the therapeutically active enantiomer. Cellulose-based polymers, hydroxypropyl methylcellulose acetate succinate (HPMCAS, MF grade) and hydroxypropyl methylcellulose (HPMC, E5 LV grade), were the best crystallization inhibitors for RS-PZQ in aqueous media and were selected for ASD preparation using solvent evaporation (SE) and hot-melt extrusion (HME). ASDs prepared experimentally were subjected to X-ray powder diffraction to verify their amorphous nature and a selected number of ASDs were monitored and found to remain physically stable following several months of storage under accelerated-stability testing conditions. SE HPMCAS-MF ASDs of RS-PZQ and R-PZQ showed faster release than HPMC E5 LV ASDs and maintained good performance with an increase in drug loading (DL). HME ASDs of RS-PZQ formulated using HPMCAS-MF exhibited slightly enhanced release compared to that of SE ASDs. SE HPMCAS-MF ASDs showed a maximum release increase of the order of 6 times compared to generic and branded (Biltricide) PZQ tablets. More importantly, SE R-PZQ ASDs with HPMCAS-MF released the drug as effectively as RS-PZQ or better, depending on the DL used. These findings have significant implications for the development of commercial PZQ formulations comprised solely of the R-enantiomer, which can result in mitigation of the biopharmaceutical and compliance issues associated with current commercial tablets.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PraziquantelMethylcelluloseHypromellose DerivativesCrystallizationDrug LiberationSolubilityStereoisomerismX-Ray DiffractionDrug CompoundingTabletsBiological AvailabilityHot Melt Extrusion TechnologyChemistry, PharmaceuticalPolymers

Stichwörter der Autor:innen

amorphous solid dispersionschiralitydrug releasepharmaceutical polymerspraziquantel

Substanzen

PraziquantelMethylcelluloseHypromellose Derivativeshydroxypropylmethylcellulose acetate succinateTabletsPolymers

Autor:innen und Institutionen

  • Department of Industrial and Molecular Pharmaceutics, College of Pharmacy, Purdue University, West Lafayette, Indiana 47907, United States.

ORCID-Profile: Lynne S Taylor

Förderung

  • Bill and Melinda Gates Foundation

Zitieren

APA

Polyzois, H., Nguyen, H. T., Roberto de Alvarenga Junior, B., & Taylor, L. S. (2024). Amorphous Solid Dispersion Formation for Enhanced Release Performance of Racemic and Enantiopure Praziquantel. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.4c00711

Vancouver

Polyzois H, Nguyen HT, Roberto de Alvarenga Junior B, Taylor LS. Amorphous Solid Dispersion Formation for Enhanced Release Performance of Racemic and Enantiopure Praziquantel. Molecular Pharmaceutics. 2024. doi:10.1021/acs.molpharmaceut.4c00711

BibTeX
@article{Polyzois2024,
  author = {Polyzois, Hector and Nguyen, Hanh Thuy and Roberto de Alvarenga Junior, Benedito and Taylor, Lynne S},
  title = {Amorphous Solid Dispersion Formation for Enhanced Release Performance of Racemic and Enantiopure Praziquantel},
  journal = {Molecular Pharmaceutics},
  year = {2024},
  doi = {10.1021/acs.molpharmaceut.4c00711}
}
Kostenlos starten →